Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Iron Overload: early-phase trial registry

2 of 7 indexed Iron Overload trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 2 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Iron Overload: 7 US clinical trials tracked, 2 recruiting.

Iron Overload is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Cornell University, running 2 of these trials.

Enrollment posture brief

Registry condition iron-overload

OPEN 2 | RECR 29% | LATE 0 | EARLY 1 | RANK #2497 | SPON 2

Nearest open-share peer: Acromegaly (29% recruiting · 14 trials)

ACL Tear71.4%ACL57.1%Acute Myelogenous Leukemia42.9%Iron Overload (this)29%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Iron Overload

Iron Overload lists 2 open slots (29% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Iron Overload on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Iron Overload is recruiting below its size-band peers.

    2 of 7 indexed trials (28.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Iron Overload research.

    Cornell University accounts for 2 of 7 trials (28.6%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Iron Overload enrolment sits around 200 participants.

    Median target enrolment is 200 among the 6 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.

  4. Iron Overload research leans observational.

    2 interventional and 5 observational studies make up this index (28.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Iron Overload records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Iron Dietary supplement
1 trials
Combination Iron Chelation Therapy Drug
1 trials
Non-contrast MRI with novel MRI software Device
1 trials
Placebo Dietary supplement
1 trials

US sites by state

Facility locations filed on Iron Overload trials. A trial with sites in several states counts in each.

New York 3 trials
California 2 trials
Wisconsin 1 trials
Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Iron Overload page

7 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Iron Overload condition card totals 7 registered trials; most-linked intervention Iron; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.